Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             39 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adult-onset idiopathic Type I or ketosis-prone Type II diabetes: evidence to revisit diabetes classification Sobngwi, E.
 2002
 45 2 p. 283-285
 artikel
2 Adult-onset idiopathic Type I or ketosis-prone Type II diabetes: evidence to revisit diabetes classification Sobngwi, E.
 2002
 45 2 p. 283-285
 artikel
3 Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy Hogeboom van Buggenum, I. M.
 2002
 45 2 p. 203-209
 artikel
4 Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy Hogeboom van Buggenum, I. M.
 2002
 45 2 p. 203-209
 artikel
5 Announcement 2002
 45 2 p. R9-R12
 artikel
6 A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes Shinoda-Tagawa, T.
 2002
 45 2 p. 188-194
 artikel
7 A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes Shinoda-Tagawa, T.
 2002
 45 2 p. 188-194
 artikel
8 Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice Shapiro, A. M. J.
 2002
 45 2 p. 224-230
 artikel
9 Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice Shapiro, A. M. J.
 2002
 45 2 p. 224-230
 artikel
10 Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes Gloyn, A. L.
 2002
 45 2 p. 290
 artikel
11 Considerations for successful transplantation of encapsulated pancreatic islets de Vos, P.
 2002
 45 2 p. 159-173
 artikel
12 Considerations for successful transplantation of encapsulated pancreatic islets de Vos, P.
 2002
 45 2 p. 159-173
 artikel
13 Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases McLennan, S. V.
 2002
 45 2 p. 268-275
 artikel
14 Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases McLennan, S. V.
 2002
 45 2 p. 268-275
 artikel
15 Erratum to: Advanced glycation end-products: a review Singh, R.
 2002
 45 2 p. 293
 artikel
16 Erratum to: Diabetes mellitus and the stomach Stacher, G.
 2002
 45 2 p. 293
 artikel
17 Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes Williams, A. J. K.
 2002
 45 2 p. 217-223
 artikel
18 Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes Williams, A. J. K.
 2002
 45 2 p. 217-223
 artikel
19 Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria Bangstad, H.-J.
 2002
 45 2 p. 253-261
 artikel
20 Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria Bangstad, H.-J.
 2002
 45 2 p. 253-261
 artikel
21 Kinetics of integrin expression in the mouse model of proliferative retinopathy and success of secondary intervention with cyclic RGD peptides Chavakis, E.
 2002
 45 2 p. 262-267
 artikel
22 Kinetics of integrin expression in the mouse model of proliferative retinopathy and success of secondary intervention with cyclic RGD peptides Chavakis, E.
 2002
 45 2 p. 262-267
 artikel
23 Losartan attenuates endothelial hyperpermeability responses to VPF and high glucose but not angiotensin II Idris, I.
 2002
 45 2 p. 291-292
 artikel
24 Metabotropic glutamate and GABAB receptors contribute to the modulation of glucose-stimulated insulin secretion in pancreatic beta cells Brice, N. L.
 2002
 45 2 p. 242-252
 artikel
25 Metabotropic glutamate and GABAB receptors contribute to the modulation of glucose-stimulated insulin secretion in pancreatic beta cells Brice, N. L.
 2002
 45 2 p. 242-252
 artikel
26 Polymorphism in the Calpain 10 gene influences glucose metabolism in human fat cells Hoffstedt, J.
 2002
 45 2 p. 276-282
 artikel
27 Polymorphism in the Calpain 10 gene influences glucose metabolism in human fat cells Hoffstedt, J.
 2002
 45 2 p. 276-282
 artikel
28 Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes Blüher, M.
 2002
 45 2 p. 210-216
 artikel
29 Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes Blüher, M.
 2002
 45 2 p. 210-216
 artikel
30 Syntaxin-3 and syntaxin-1A inhibit L-type calcium channel activity, insulin biosynthesis and exocytosis in beta-cell lines Kang, Y.
 2002
 45 2 p. 231-241
 artikel
31 Syntaxin-3 and syntaxin-1A inhibit L-type calcium channel activity, insulin biosynthesis and exocytosis in beta-cell lines Kang, Y.
 2002
 45 2 p. 231-241
 artikel
32 The Author's Reply Lindner, T. H.
 2002
 45 2 p. 287-288
 artikel
33 The Author's Reply Wilkin, T.
 2002
 45 2 p. 289
 artikel
34 The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men Agersø, H.
 2002
 45 2 p. 195-202
 artikel
35 The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men Agersø, H.
 2002
 45 2 p. 195-202
 artikel
36 - to: Lindner T, Cockburn BN, Bell GI (1999) Molecular genetics of MODY in Germany. Diabetologia 42: 121–123 Ziemssen, F.
 2002
 45 2 p. 286-287
 artikel
37 - to: T. J. Wilkin (2001) The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes. Diabetologia 44: 914–921 Gorus, F. K.
 2002
 45 2 p. 288-289
 artikel
38 Uncoupling protein-2: evidence for its function as a metabolic regulator Saleh, M. C.
 2002
 45 2 p. 174-187
 artikel
39 Uncoupling protein-2: evidence for its function as a metabolic regulator Saleh, M. C.
 2002
 45 2 p. 174-187
 artikel
                             39 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland